Piper Jaffray Upgrades Catalyst Pharmaceutical Partners (CPRX) to Overweight
Tweet Send to a Friend
Piper Jaffray upgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) from Neutral to Overweight with a price target of $4.00 (from $1.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
